[HTML] nih.gov

Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up

V Maestrini, LI Birtolo, M Francone, G Galardo… - International journal of …, 2021 - Elsevier
Background Cardiovascular disease (CVD) can occur in COVID-19 and has impact on
clinical course. Data on CVD prevalence in hospitalized COVID-19 patients and sequelae in …
被引用次数：40 相关文章 所有 12 个版本
[HTML] nih.gov

[HTML][HTML] Characteristics and outcomes of hospitalized patients with cardiovascular complications of COVID-19

F Jalali, F Hatami, M Saravi, I Jafaripour… - … of Cardiovascular and …, 2021 - ncbi.nlm.nih.gov
Introduction: To address cardiovascular (CV) complications and their relationship to clinical
outcomes in hospitalized patients with COVID-19. Methods: A total of 196 hospitalized …
被引用次数：13 相关文章 所有 14 个版本
[HTML] springer.comFull View

[HTML][HTML] Cardiovascular involvement in COVID-19: what sequelae should we expect?

MV Polito, A Silverio, M Bellino, G Iuliano… - Cardiology and …, 2021 - Springer
Several forms of cardiovascular involvement have been described in patients with
Coronavirus disease 19 (COVID-19): myocardial injury, acute coronary syndrome, acute …
被引用次数：20 相关文章 所有 7 个版本
[HTML] sciencedirect.com

[HTML][HTML] Cardiovascular complications and its impact on outcomes in COVID-19

S Kunal, SM Sharma, SK Sharma, D Gautam… - Indian heart …, 2020 - Elsevier
Abstract Background Coronavirus disease 2019 (COVID-19) has led to a widespread
morbidity and mortality. Limited data exists regarding the involvement of cardiovascular …
被引用次数：51 相关文章 所有 8 个版本
[HTML] oup.com

Cardiac complications in patients hospitalised with COVID-19

M Linschoten, S Peters, M van Smeden… - … Heart Journal: Acute …, 2020 - academic.oup.com
Aims: To determine the frequency and pattern of cardiac complications in patients
hospitalised with coronavirus disease (COVID-19). Methods and results: CAPACITY-COVID …
被引用次数：161 相关文章 所有 15 个版本
[HTML] nih.gov

[HTML][HTML] COVID-19 and cardiovascular complications–preliminary results of the LATE-COVID study

J Lewek, I Jatczak-Pawlik, M Maciejewski… - Archives of Medical …, 2021 - ncbi.nlm.nih.gov
Methods We analysed consecutive patients (n= 51) admitted to the cardiology department
between 1 st October 2020 and 31 st January 2021 due to symptoms which might have …
被引用次数：43 相关文章 所有 12 个版本
[HTML] oup.com

Defining heart disease risk for death in COVID-19 infection

J Li, T Guo, D Dong, X Zhang, X Chen… - … Journal of Medicine, 2020 - academic.oup.com
Background Cardiovascular disease (CVD) was in common in coronavirus disease 2019
(COVID-19) patients and associated with unfavorable outcomes. We aimed to compare the …
被引用次数：40 相关文章 所有 8 个版本
[PDF] latunisiemedicale.com

[PDF][PDF] COVID-19 et Maladies cardiovasculaires. Etude scoping review COVID-19 and Cardiovascular diseases. Scoping review study

F Yahia, L Zakhama, AB Abdelaziz… - La Tunisie …, 2020 - latunisiemedicale.com
Introduction: Many patients with COVID-19 have pre-existing cardiovascular (CV) co-
morbidities or develop acute heart damage during the course of the disease. Objectives: To …
被引用次数：27 相关文章 所有 3 个版本
[PDF] viamedica.pl

Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19

GC Villalba, IJ Amat-Santos, C Duenas… - Cardiology …, 2021 - journals.viamedica.pl
Background: Cardiovascular risk factors and usage of cardiovascular medication are
prevalent among coronavirus disease 2019 (COVID-19) patients. Little is known about the …
被引用次数：19 相关文章 所有 11 个版本
[HTML] nih.gov

Mortality associated with cardiovascular disease in patients with COVID-19

A Cordero, CS García-Gallego, V Bertomeu-González… - REC …, 2021 - Elsevier
Introduction and objectives Cardiovascular disease (CVD) has been outlined as a possible
risk factor for poorer outcomes in patients with COVID-19. Methods A meta-analysis was …
被引用次数：28 相关文章 所有 4 个版本